ACE2 and cardiovascular disorder: As ACE2 is closely implicated with higher risks of cardiovascular complications and development of cardiovascular diseases, dysfunction of ACE2 after virus binding and dysregulation of the renin-angiotensin-aldosterone system (RAAS) signaling may worsen the outcomes of people affected by COVID-19 and with preexisting cardiovascular diseases (29).